Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) and chemoradiotherapy
resistance, we discussed the feasibility for lncRNAs as therapeutic targets. Finally
Shnayder, Natalia A.,
Ashhotov, Azamat V.,
Trefilova, Vera V.,
Novitsky, Maxim A.,
Medvedev, German V.,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Kaskaeva, Daria S.,
Chumakova, Galina A.,
Garganeeva, Natalia P.,
Lareva, Natalia V.,
Al-Zamil, Mustafa,
Asadullin, Azat R.,
Nasyrova, Regina F. (2023) . It demonstrates promise of new approaches to IDD management in patients
resistant to previously used therapies
Kudriashov, Valentin,
Sufianov, Albert,
Mashkin, Andrey,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Lyulin, Sergey,
Beylerli, Ozal (2023) and protein, such as adipocyte proliferation and dif-
ferentiation, inflammation, and insulin
resistance